UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C.
20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
Commission File Number: 001-38758
LUNAI BIOWORKS, INC.
(Exact name of registrant as specified in its charter)
3400 Cottage Way, Suite G2, #32562, Sacramento,
California 95825; (424) 222-9301
(Address, including zip code, and telephone number,
including area code, of registrant’s principal executive offices)
Common Stock, par value $0.0001 per share
(Title of each class of securities covered by this
Form)
None
(Titles of all other classes of securities for which
a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s)
relied upon to terminate or suspend the duty to file reports:
| Rule 12g-4(a)(1) |
☒ |
| Rule 12g-4(a)(2) |
☐ |
| Rule 12h-3(b)(1)(i) |
☐ |
| Rule 12h-3(b)(1)(ii) |
☐ |
| Rule 15d-6 |
☒ |
| Rule 15d-22(b) |
☐ |
Approximate number of holders of record as of the certification or notice
date: 231
Pursuant to the requirements of the Securities Exchange Act of 1934, Lunai
Bioworks, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
| Date: November 12, 2026 |
LUNAI BIOWORKS, INC. |
| |
|
| |
By: |
/s/ David Weinstein |
| |
Name: |
David Weinstein |
| |
Title: |
Chief Executive Officer |
| |
|